Gene · 3872
Papers3,832
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,832
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma. | Am J Dermatopathol | 2022 | 36197047 | PubTator, text mining | PubMed |
| The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion. | Clin Cosmet Investig Dermatol | 2022 | 36193053 | PubTator, text mining | PubMed |
| Wnt-activating human skin organoid model of atopic dermatitis induced by Staphylococcus aureus and its protective effects by Cutibacterium acnes. | iScience | 2022 | 36193049 | PubTator, text mining | PubMed |
| Treatment-associated remodeling of the pancreatic cancer endothelium at single-cell resolution. | Front Oncol | 2022 | 36185212 | PubTator, text mining | PubMed |
| MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | Genome Biol | 2022 | 36180891 | PubTator, text mining | PubMed |
| The urothelium: a multi-faceted barrier against a harsh environment. | Mucosal Immunol | 2022 | 36180582 | PubTator, text mining | PubMed |
| Portable Cold Atmospheric Plasma Patch-Mediated Skin Anti-Inflammatory Therapy. | Adv Sci (Weinh) | 2022 | 36180414 | PubTator, text mining | PubMed |
| Airway basal cells show regionally distinct potential to undergo metaplastic differentiation. | Elife | 2022 | 36178196 | PubTator, text mining | PubMed |
| Applications of human organoids in the personalized treatment for digestive diseases. | Signal Transduct Target Ther | 2022 | 36167824 | PubTator, text mining | PubMed |
| Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis. | Nat Commun | 2022 | 36163190 | PubTator, text mining | PubMed |
| Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma. | Front Immunol | 2022 | 36159831 | PubTator, text mining | PubMed |
| Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker. | Ecancermedicalscience | 2022 | 36158981 | PubTator, text mining | PubMed |
| Molecular mechanisms of Biyu decoction as treatment for psoriasis: A network pharmacology and molecular docking study. | World J Clin Cases | 2022 | 36158000 | PubTator, text mining | PubMed |
| Application of extracellular vesicles from mesenchymal stem cells promotes hair growth by regulating human dermal cells and follicles. | World J Stem Cells | 2022 | 36157528 | PubTator, text mining | PubMed |
| Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays. | Mol Cell Proteomics | 2022 | 36152753 | PubTator, text mining | PubMed |
| Effects of PPAR-γ and RXR-α on mouse meibomian gland epithelial cells during inflammation induced by latanoprost. | Exp Eye Res | 2022 | 36150542 | PubTator, text mining | PubMed |
| A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation. | Elife | 2022 | 36149401 | PubTator, text mining | PubMed |
| PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. | Int J Biol Sci | 2022 | 36147463 | PubTator, text mining | PubMed |
| Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Oral Cancer. | Vaccines (Basel) | 2022 | 36146567 | PubTator, text mining | PubMed |
| Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities. | Microorganisms | 2022 | 36144454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3872/papers?page=39